"Rather than pursue our individual research, we are putting public and patient health first by working together. Our goals are to accelerate the development of a potential treatment, improve our chances of success, and increase supply of the potential treatment.
"In addition to those announced at its inception—Biotest, BPL, CSL Behring, LFB, Octapharma, and Takeda—the Alliance welcomes new industry members ADMA Biologics, BioPharma Plasma, GC Pharma, and Sanquin. The Bill & Melinda Gates Foundation is providing advisory support.
"Microsoft is providing technology including the Alliance website and the Plasma Bot for donor recruitment."
What Is CoVIg-19?
Plasma from people who have recovered from COVID-19 — known as “convalescent plasma” — could be a key part of the fight against the new coronavirus. Once the plasma is donated, it can take one of two paths: be directly transfused into patients, or used to make a potential medicine for COVID-19.
Both of these approaches are important and some hospitals are already using direct transfusion to treat severe COVID-19 patients.
The CoVIg-19 Plasma Alliance is developing a hyperimmune globulin (H-Ig) called CoVIg-19. This potential medicine requires plasma donated by people who have fully recovered from COVID-19, since their plasma contains antibodies against the virus.
If interested in helping visit: https://www.donatingplasma.org and/or https://www.covig-19plasmaalliance.org/en-us#recruitment
No comments:
Post a Comment